BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 21531726)

  • 1. p53 negatively regulates RGS13 protein expression in immune cells.
    Iwaki S; Lu Y; Xie Z; Druey KM
    J Biol Chem; 2011 Jun; 286(25):22219-26. PubMed ID: 21531726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RGS13 controls g protein-coupled receptor-evoked responses of human mast cells.
    Bansal G; DiVietro JA; Kuehn HS; Rao S; Nocka KH; Gilfillan AM; Druey KM
    J Immunol; 2008 Dec; 181(11):7882-90. PubMed ID: 19017978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RGS13 regulates germinal center B lymphocytes responsiveness to CXC chemokine ligand (CXCL)12 and CXCL13.
    Shi GX; Harrison K; Wilson GL; Moratz C; Kehrl JH
    J Immunol; 2002 Sep; 169(5):2507-15. PubMed ID: 12193720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RGS13 acts as a nuclear repressor of CREB.
    Xie Z; Geiger TR; Johnson EN; Nyborg JK; Druey KM
    Mol Cell; 2008 Sep; 31(5):660-70. PubMed ID: 18775326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of immunoglobulin E-mediated allergic responses by regulator of G protein signaling 13.
    Bansal G; Xie Z; Rao S; Nocka KH; Druey KM
    Nat Immunol; 2008 Jan; 9(1):73-80. PubMed ID: 18026105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extension of the germinal center stage of B cell development promotes autoantibodies in BXD2 mice.
    Wang JH; New JS; Xie S; Yang P; Wu Q; Li J; Luo B; Ding Y; Druey KM; Hsu HC; Mountz JD
    Arthritis Rheum; 2013 Oct; 65(10):2703-12. PubMed ID: 23818250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wild type p53 transcriptionally represses the SALL2 transcription factor under genotoxic stress.
    Farkas C; Martins CP; Escobar D; Hepp MI; Castro AF; Evan G; Gutiérrez JL; Warren R; Donner DB; Pincheira R
    PLoS One; 2013; 8(9):e73817. PubMed ID: 24040083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rgs13 constrains early B cell responses and limits germinal center sizes.
    Hwang IY; Hwang KS; Park C; Harrison KA; Kehrl JH
    PLoS One; 2013; 8(3):e60139. PubMed ID: 23533672
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional Characterization of Nupr1L, A Novel p53-Regulated Isoform of the High-Mobility Group (HMG)-Related Protumoral Protein Nupr1.
    Lopez MB; Garcia MN; Grasso D; Bintz J; Molejon MI; Velez G; Lomberk G; Neira JL; Urrutia R; Iovanna J
    J Cell Physiol; 2015 Dec; 230(12):2936-50. PubMed ID: 25899918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of RGS13 by the cyclic AMP-dependent protein kinase inhibits RGS13 degradation.
    Xie Z; Yang Z; Druey KM
    J Mol Cell Biol; 2010 Dec; 2(6):357-65. PubMed ID: 20974683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genome-wide analysis of p53 transcriptional programs in B cells upon exposure to genotoxic stress in vivo.
    Tonelli C; Morelli MJ; Bianchi S; Rotta L; Capra T; Sabò A; Campaner S; Amati B
    Oncotarget; 2015 Sep; 6(28):24611-26. PubMed ID: 26372730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 stimulates transcription from the human transforming growth factor alpha promoter: a potential growth-stimulatory role for p53.
    Shin TH; Paterson AJ; Kudlow JE
    Mol Cell Biol; 1995 Sep; 15(9):4694-701. PubMed ID: 7651386
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumour suppressor protein p53 regulates the stress activated bilirubin oxidase cytochrome P450 2A6.
    Hu H; Yu T; Arpiainen S; Lang MA; Hakkola J; Abu-Bakar A
    Toxicol Appl Pharmacol; 2015 Nov; 289(1):30-9. PubMed ID: 26343999
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of regulatory regions within the KAI1 promoter: a role for binding of AP1, AP2 and p53.
    Marreiros A; Czolij R; Yardley G; Crossley M; Jackson P
    Gene; 2003 Jan; 302(1-2):155-64. PubMed ID: 12527206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of the G protein regulator RGS13.
    Johnson EN; Druey KM
    J Biol Chem; 2002 May; 277(19):16768-74. PubMed ID: 11875076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RGS1 and RGS13 mRNA silencing in a human B lymphoma line enhances responsiveness to chemoattractants and impairs desensitization.
    Han JI; Huang NN; Kim DU; Kehrl JH
    J Leukoc Biol; 2006 Jun; 79(6):1357-68. PubMed ID: 16565322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcriptional regulation of the human DNA polymerase delta catalytic subunit gene POLD1 by p53 tumor suppressor and Sp1.
    Li B; Lee MY
    J Biol Chem; 2001 Aug; 276(32):29729-39. PubMed ID: 11375983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network.
    Menendez D; Krysiak O; Inga A; Krysiak B; Resnick MA; Schönfelder G
    Proc Natl Acad Sci U S A; 2006 Jan; 103(5):1406-11. PubMed ID: 16432214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.
    Phan RT; Dalla-Favera R
    Nature; 2004 Dec; 432(7017):635-9. PubMed ID: 15577913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bradykinin type 2 receptor is a target for p53-mediated transcriptional activation.
    Saifudeen Z; Du H; Dipp S; El-Dahr SS
    J Biol Chem; 2000 May; 275(20):15557-62. PubMed ID: 10748162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.